1Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J]. Am J Cardiol,2001,88(3) :230.
2Sane DC, McKee SA, Malinin AI, et al. Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin[J]. Am J Cardiol,2002,90(8):893.
3Rocca B, Secchiero P, Ciabattoni G, et al. Cyclooxygenase-2 expression is inducel during human megakaryopoesis and characterizes newly formed platelets[J]. Proc Natl Acad Sci, 2002,99( 11 ) :7634.
4Cipollone F, Ciabattoni G, Patrignani P, et al. Oxidant stress and aspirin insensitive thromboxane biosynthesis in severe unstable angina[J]. Circulation,2000,102(9): 1007.
5Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibiors and the antiplatelet effects of aspirin[J]. N Engl J Med, 2001,345 (25):1809.
6Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel [J]. Circulation,1999,100(15): 1667.
7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to as pirin in patients with acute coronary syndromes without ST-segment elevation[J]. N Engl J Med, 2001,345 (7) :494.
8Steinhubl SR, Berger PB, Tift Mann J, et al. Early and sustained udal oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial[J]. JAMA, 2002,288 (19): 2411.
9Patti G, Colonna G Pasceri V, et al. Randomized trial of high loadingdose of clopidogrel for reduction of periproccdural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (attiplatelet therapy for reduction of myocardial damage during angioplasty ) study [J]. Circulation, 2005,111 ( 16 ): 2099.
10Sabatine MS, Cannon CP, Gibson CM. CLARITY-TIMI28 Investigators. addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation [J]. N Engl J Med, 2005, 352 (12): 1179.
